Corona Remedies’ ₹655.37 crore IPO has garnered investor interest ahead of its allotment date on December 11, 2025. The issue, which is entirely an offer for sale of 0.62 crore equity shares, opened for subscription on December 8 and closed on December 10.
Corona Remedies IPO witnessed exceptional demand on the final day, closing with an overall subscription of 144.54 times. The retail portion was subscribed 30.39 times, indicating strong participation from individual investors.
The NII category saw overwhelming interest at 220.18 times, while the QIB (excluding anchor investors) portion was booked an extraordinary 293.80 times.
The price band for the issue was set between ₹1008 and ₹1062 per share. Once allotment is finalised, the refund initiation and share credit processes will follow, leading up to the tentative listing on December 15, 2025, on both BSE and NSE. Bigshare Services Pvt. Ltd is the registrar responsible for allotment processing and investor queries.
Investors can check their allotment status through multiple platforms. The simplest method is to visit the registrar Bigshare Services’ website and enter application number, PAN or DP ID/Client ID to view the status once updated.
Alternatively, both BSE and NSE provide allotment-checking facilities where applicants can select the issue name and enter their credentials. Allotment status generally becomes visible by evening on the allotment date or the following morning.
Also Read: Leap India, Technocraft Ventures, and 3 Other IPOs Receive Green Signal from SEBI!
With a 144.54 times subscription, the Corona Remedies IPO has captured investor attention. As the allotment is set to be finalised on December 11, applicants are advised to check their status through the registrar or stock exchange portals and track further updates leading to the listing on December 15. Those who receive shares can expect them to be credited directly to their demat account ahead of the listing on December 15.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a private recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Dec 11, 2025, 10:50 AM IST
Nikitha Devi
Nikitha is a content creator with 7+ years of experience in the financial domain. Specialising in personal finance, investments, and market insights, Nikitha simplifies complex financial topics, making them accessible to readers.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
